Biocidal Products

Products containing active substances intended to destroy or control harmful organisms, subject to authorisation, labeling, and market surveillance under dedicated regulation.

Foresight tracks Biocidal Products developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.

Not ready for a trial? Take the 3-minute readiness assessment

Current activity

Intensifying

43% above the prior 8-week baseline

3-month trend

Latest alerts below

Last updated

25 May 2026, 15:53

View alerts

Latest Biocidal Products developments

Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.

ECHA Removes Baker Hughes From Article 95 Supplier List for Acrylaldehyde (CAS 107-02-8, PT 12)

In May 2026, ECHA updated the Article 95 list of biocidal active substance suppliers, with the new list showing that Baker Hughes (Netherland) B.V. is no longer an Article 95-listed supplier of Acrylaldehyde (EC 203-453-4, CAS 107-02-8) for product-type 12. Companies that relied on this listing to place PT 12 biocidal products on the EU market now need to secure an alternative Article 95-compliant supply route or their own listing to maintain regulatory compliance and avoid disruption.

echa.europa.euEuropean UnionEuropean UnionNetherlandsNetherlands

ECHA Updates BPR Review Programme List of Notifications With Hydrogen Peroxide, TCDO and Geraniol 2

ECHA has updated the BPR Review Programme List of Notifications as of 20 May 2026, adding new compliant entries for hydrogen peroxide (product-type 11) and TCDO-generated chlorine dioxide and newly listing Geraniol2 and hydrogen peroxide (product-type 12) as unsupported combinations. This clarifies which biocidal uses must now be backed by active substance applications (including a 8 January 2027 deadline for TCDO) and signals imminent non-approval and phase-out for several active substances, requiring suppliers and formulators to reassess portfolios and plan substitutions or withdrawals.

echa.europa.euEuropean UnionEuropean Union

EU ECHA Removes LANXESS as Article 95 Supplier for Thiamethoxam

ECHA’s 20 May 2026 Article 95 list update under the Biocidal Products Regulation shows LANXESS Deutschland GmbH is no longer registered as an active substance supplier for Thiamethoxam (CAS 153719-23-4, PT 8). EU companies relying on LANXESS for Thiamethoxam-based biocidal products must ensure they source from another Article 95-listed supplier or hold their own compliant dossier to avoid market access disruption and regulatory non-compliance.

echa.europa.euEuropean UnionEuropean Union

ECHA Removes Rio Tinto as Article 95 Supplier for Diboron Trioxide (CAS 1303-86-2)

ECHA’s 20 May 2026 update to the Article 95 list removed Rio Tinto Iron & Titanium GmbH (acting for Borax Europe Limited) as a listed supplier of Diboron trioxide (PT 8) in the EU. This eliminates that Article 95 supply route, so biocidal product manufacturers depending on this supplier must secure an alternative listed supplier or listing arrangement to maintain market access.

echa.europa.euEuropean UnionEuropean Union

EU Commission Postpones PHMB (1415; 4.7) Approval Expiry for Biocidal Product Types 2 and 4 to April 2029

The European Commission has adopted an implementing decision extending the EU approval of PHMB (1415; 4.7) for biocidal product types 2 and 4, with the new expiry date set at 30 April 2029. This postponement gives manufacturers and authorisation holders more time to manage PHMB-based disinfectant portfolios and renewal dossiers, but they should still plan around 2029 as the key horizon for continued EU market access for these uses.

ec.europa.euEuropean UnionEuropean Union

EU Commission Postpones Expiry of Disodium Tetraborate Approval for Biocidal Product-Type 8

In May 2026 the European Commission adopted an implementing decision under the EU Biocidal Products Regulation to postpone the expiry of the approval of disodium tetraborate as an active substance in product-type 8 biocidal products. This keeps this borate-based preservative legally available for longer in PT 8 biocidal formulations, so companies relying on it should plan for continued use while monitoring for the eventual new expiry date and any related conditions.

ec.europa.euEuropean UnionEuropean Union

European Commission Extends Polish Authorisation for Biocidal Product Biobor JF

In May 2026 the European Commission adopted an implementing decision extending Poland’s authorisation to keep the biocidal product Biobor JF on the market under the EU Biocidal Products Regulation. This prolongs legal certainty for Polish users and suppliers of Biobor JF, but companies should monitor for the official decision text to confirm the new validity period and any updated conditions.

ec.europa.euEuropean UnionEuropean UnionPolandPoland

EU Commission Adopts Implementing Decision Not Renewing Cypermethrin Approval for Biocidal Product-Type 8

In May 2026 the European Commission adopted an Implementing Decision, recorded as C(2026)2900, not to renew cypermethrin’s EU approval for biocidal product-type 8 under the Biocidal Products Regulation. Manufacturers and users of cypermethrin-based product-type 8 biocides should anticipate an EU-wide phase-out and start planning substitutions and market adjustments now, even though detailed withdrawal and use-by dates will only be confirmed once the Official Journal text is available.

ec.europa.euEuropean UnionEuropean Union

EU Commission Postpones Expiry Date of IPBC Approval for Biocidal Product-Type 8

In May 2026 the European Commission issued an implementing decision postponing the expiry date of the EU approval of the active substance IPBC for biocidal product-type 8 wood preservatives. This extension keeps IPBC-based wood preservatives legally on the EU market for longer, giving biocide manufacturers more time to manage approval renewals, substitution strategies, and downstream customer planning.

ec.europa.euEuropean UnionEuropean Union

EU Commission Postpones Expiry of Boric Acid Approval for Biocidal Product-Type 8

The European Commission has adopted an Implementing Decision to postpone the expiry of the EU approval of boric acid as an active substance for use in product-type 8 biocidal products under the Biocidal Products Regulation. This extension keeps boric-acid-based PT 8 biocidal products on the EU market for longer while renewal is assessed, giving manufacturers and authorisation holders more time to plan portfolio and data strategies without easing existing compliance obligations.

ec.europa.euEuropean UnionEuropean Union

EU Commission Postpones Glutaraldehyde Biocidal Approval (PT 2, 3, 4, 6, 11, 12) To 31 March 2029

The European Commission is postponing the BPR approval expiry for glutaraldehyde in several disinfectant and preservative product-types from 30 September 2026 to 31 March 2029. This extension keeps glutaraldehyde-based biocidal products on the EU market while renewal assessments are completed, giving companies more time but signalling that conditions of use may change once the review concludes.

ec.europa.euEuropean UnionEuropean Union

EU Commission Repeals Cypermethrin Biocidal Product-Type 8 Approval Expiry Postponement

In May 2026 the European Commission registered an implementing decision that will repeal the 2025 measure postponing the EU approval expiry date for cypermethrin as an active substance in biocidal product-type 8 under the Biocidal Products Regulation. This removes the previous extension of approval until 30 November 2027 and signals that a new renewal or non-renewal decision is nearing, so companies relying on cypermethrin PT8 wood-preservative products should reassess market access, reformulation options, and transition plans.

ec.europa.euEuropean UnionEuropean Union

EU Commission Postpones Expiry of Medetomidine Approval for PT 21 Biocidal Products to 31 December 2026

In May 2026 the European Commission extended the EU approval of the biocidal active substance medetomidine for product-type 21 uses under the Biocidal Products Regulation until 31 December 2026. This extension avoids a near-term regulatory gap for antifouling products while signalling ongoing scrutiny of medetomidine’s endocrine-disrupting profile and the need to prepare for a future renewal or non-renewal decision.

eur-lex.europa.euEuropean UnionEuropean Union

EU Extends Medetomidine PT21 Biocidal Approval To 31 December 2026

The European Commission has extended the EU approval of the biocidal active substance medetomidine (product-type 21) until 31 December 2026 while renewal discussions continue. This keeps existing antifouling products using medetomidine on the market under unchanged conditions for an additional six months but signals that a stricter decision could follow once its endocrine-disruptor status is fully evaluated.

eur-lex.europa.euEuropean UnionEuropean Union

Commission Implementing Decision (EU) 2026/1089 Postpones Medetomidine PT 21 Biocidal Approval Expiry To 31 December 2026

The European Commission has adopted Implementing Decision (EU) 2026/1089, extending EU approval of the biocidal active substance medetomidine (product-type 21) until 31 December 2026 while renewal under the Biocidal Products Regulation continues. This short extension prevents a regulatory gap but, given medetomidine’s classification as having endocrine-disrupting properties, companies using it in PT 21 products should prepare for a potentially more restrictive renewal decision and plan product and supply strategies accordingly.

eur-lex.europa.euEuropean UnionEuropean Union

Rhode Island Senate Calendars Rodent Integrated Pest Management Bill S2795

Rhode Island’s Senate has scheduled Bill S2795, which would create municipal rodent integrated pest management pilot programs, for consideration on its 26 May 2026 calendar. If the bill advances, pest control providers and municipalities in Rhode Island should expect more structured, state-supervised IPM programmes and closer oversight of how rodenticide use is planned, documented, and reported.

webserver.rilegislature.govUnited StatesUnited States

EU Commission Makes Administrative Amendments to Union Authorisation for Taski‑Room Care‑Suma Lactic Acid Biocidal Family (Implementing Regulation (EU) 2026/700)

Commission Implementing Regulation (EU) 2026/700 introduces purely administrative amendments to the existing Union authorisation for the lactic-acid biocidal product family Taski-Room Care-Suma, updating the authorisation holder address and manufacturer details without changing the authorised uses or risk conclusions. Companies relying on this union authorisation face no new substantive obligations, but should ensure product labelling, regulatory records, and internal documentation reflect the revised holder and manufacturer information.

gazzettaufficiale.itEuropean UnionEuropean Union

German CA Urges More Self‑Reactivity Testing For Hydrogen Peroxide Below 42.5% In CLP 25th ATP Process

In May 2026, the German Competent Authority for REACH and CLP endorsed RAC’s proposed oxidising classification thresholds for hydrogen peroxide in the planned 25th ATP to CLP but warned that self-reactive properties may remain relevant for solutions below 42.5%, especially in biocidal products. This signals that EU assessors may increasingly expect additional self-reactivity testing and physical-hazard justification for hydrogen peroxide formulations below current harmonised thresholds, raising future compliance and testing burdens for biocide and other mixture manufacturers.

circabc.europa.euEuropean UnionEuropean UnionGermanyGermany

EU Commission Requests ECHA Opinion On BCDMH Mutagenicity For Biocidal Product-Types 2, 11 And 12

The European Commission has asked ECHA’s Biocidal Products Committee to re-open its assessment of the active substance BCDMH for biocidal product-types 2, 11 and 12 by defining specific mutagenicity studies, allowing the applicant to submit new data, and revising earlier opinions that recommended non-approval due to a data gap. This re-evaluation could change whether BCDMH-based biocidal products can ultimately be approved in the EU, so active substance holders and formulators should closely track the new testing requirements, data deadlines, and any revised scientific opinions.

echa.europa.euEuropean UnionEuropean Union

EU Commission Mandate for ECHA Opinion on Epsilon‑Metofluthrin PT19 Indoor Cockroach Use

The European Commission has mandated ECHA’s Biocidal Products Committee to re-assess the efficacy and human and environmental risks of epsilon-metofluthrin in PT19 biocidal products used for indoor crack-and-crevice cockroach treatment, and to revise its earlier opinion on the substance. This re-opening of the assessment could change the current non-approval trajectory for epsilon-metofluthrin repellents in the EU, so biocide manufacturers and pest-control product suppliers should closely track the outcome and prepare for potential data requests or altered approval conditions.

echa.europa.euEuropean UnionEuropean Union

Not a newsletter. Not a feed. Structured intelligence mapped to your business.

These are just a few of the most recent Biocidal Products alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.

Start free trial

Topic context

How to read Biocidal Products regulatory activity

Definition

What is Biocidal Products?

Products containing active substances intended to destroy or control harmful organisms, subject to authorisation, labeling, and market surveillance under dedicated regulation.

Industry relevance

Why it matters

Biocidal Products developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.

Foresight tracking

How Foresight monitors it

Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.

Frequently asked questions

Everything you need to know about Foresight's regulatory intelligence platform

Still have questions? Get in touch with our team

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX